Omar El Sewify
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Omar El Sewify has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Jack Legler
Faculty of Medicine and Health Sciences, McGill University, Montreal, QC, Canada
4 shared publications - Johnny Ionut Efanov
Division of Plastic and Reconstructive Surgery, Centre Hôspitalier de l’Université de Montreal, Montreal, Quebec, Canada
4 shared publications - Marion Sylvain
McGill University
3 shared publications Ammara Ghumman
University of Toronto
1 shared publication- Andre Eu Jin Cheah
Hand and Reconstructive Microsurgery, National University Hospital (NUH), 5 Lower Kent Ridge Rd, Singapore
1 shared publication - Andrew Gorgy
McGill University Health Center
1 shared publication
Latest Publications
- Open Access
- 30 September 2026
- Published by SAGE Publications in Plastic Surgery
Diagnostic Accuracy and Predictive Factors of Sentinel Lymph Node Biopsy in Cutaneous Squamous Cell Carcinoma: A Systematic Review
Introduction: Sentinel lymph node biopsy (SLNB) is increasingly used to stage cutaneous squamous cell carcinoma (cSCC), particularly in high-risk cases, though its diagnostic accuracy remains debated. This systematic review aims to evaluate SLNB detection rates, diagnostic accuracy, complications and predictors of positivity in patients with non-mucosal cSCC. Methods: Following PRISMA guidelines, Medline, Embase, Scopus and Cochrane Library were searched to January 2025. Studies reporting SLNB outcomes in histologically confirmed cSCC were included. Pediatric and mucosal/anogenital cases were excluded. Data on demographics, tumour characteristics, SLNB outcomes and complications were extracted. Comparisons between SLNB-positive, negative and false-negative groups were performed ( p < 0.05). Results: Forty-four studies (3043 patients, 3050 lesions) were included. Among 2956 patients undergoing SLNB, nodes were identified in 96.9%, with positivity in 10.9%. False negatives occurred in 1.7% of the cases (rate 13.2%). SLNB-positive patients had larger tumours (4.24 vs 2.88 cm, p < 0.0001) and deeper invasion (9.81 vs 4.75 mm, p = 0.0007), higher rates of perineural invasion ( p = 0.0436), poor differentiation ( p = 0.009) and more T2 disease ( p = 0.04). No significant differences were found for sex ( p = 0.5), immunosuppression ( p = 0.068) or tumour location ( p = 0.1), though immunosuppression was more prevalent in SLNB-positive cases. Recurrence (24.3% vs 4.2%) and disease-specific mortality (18.2% vs 3.7%) were higher in SLNB-positive patients ( p < 0.0002). Complication rates were low (3.2%). Conclusion: SLNB demonstrates high detection but notable false negative rates in cSCC. Positive SLNB correlates with aggressive tumour features and worse outcomes. SLNB may assist staging in high-risk patients but should be used selectively, with close surveillance in SLNB-negative cases.
- 30 September 2026
- Published by SAGE Publications in Plastic Surgery
Open AccessDiagnostic Accuracy and Predictive Factors of Sentinel Lymph Node Biopsy in Cutaneous Squamous Cell Carcinoma: A Systematic Review
Introduction: Sentinel lymph node biopsy (SLNB) is increasingly used to stage cutaneous squamous cell carcinoma (cSCC), particularly in high-risk cases, though its diagnostic accuracy remains debated. This systematic review aims to evaluate SLNB detection rates, diagnostic accuracy, complications and predictors of positivity in patients with non-mucosal cSCC. Methods: Following PRISMA guidelines, Medline, Embase, Scopus and Cochrane Library were searched to January 2025. Studies reporting SLNB outcomes in histologically confirmed cSCC were included. Pediatric and mucosal/anogenital cases were excluded. Data on demographics, tumour characteristics, SLNB outcomes and complications were extracted. Comparisons between SLNB-positive, negative and false-negative groups were performed ( p < 0.05). Results: Forty-four studies (3043 patients, 3050 lesions) were included. Among 2956 patients undergoing SLNB, nodes were identified in 96.9%, with positivity in 10.9%. False negatives occurred in 1.7% of the cases (rate 13.2%). SLNB-positive patients had larger tumours (4.24 vs 2.88 cm, p < 0.0001) and deeper invasion (9.81 vs 4.75 mm, p = 0.0007), higher rates of perineural invasion ( p = 0.0436), poor differentiation ( p = 0.009) and more T2 disease ( p = 0.04). No significant differences were found for sex ( p = 0.5), immunosuppression ( p = 0.068) or tumour location ( p = 0.1), though immunosuppression was more prevalent in SLNB-positive cases. Recurrence (24.3% vs 4.2%) and disease-specific mortality (18.2% vs 3.7%) were higher in SLNB-positive patients ( p < 0.0002). Complication rates were low (3.2%). Conclusion: SLNB demonstrates high detection but notable false negative rates in cSCC. Positive SLNB correlates with aggressive tumour features and worse outcomes. SLNB may assist staging in high-risk patients but should be used selectively, with close surveillance in SLNB-negative cases.
- Open Access
- 31 August 2026
- Published by SAGE Publications in Plastic Surgery
Patient Perspective on Preoperative Simulation in Plastic Surgery: A Systematic Review of Patient-Reported Outcomes
Introduction: Preoperative simulation technologies are increasingly utilized in plastic surgery to enhance surgical planning and patient communication. While their technical benefits have been established, the impact on patient-reported outcomes (PROs), in particular satisfaction and perceived accuracy, remain underexplored. This systematic review evaluated the effect of preoperative simulation on patient-reported satisfaction, decision-making, and perceived accuracy in breast and facial aesthetic plastic surgery. Methods: A systematic search of MEDLINE, Embase, and Cochrane databases up to April 2025 identified studies reporting PROs in adult patients undergoing breast (aesthetic or reconstructive) or facial aesthetic surgery with preoperative simulation. Data on demographics, simulation type, satisfaction, accuracy, and complications were extracted and analyzed. Results: Seventeen studies (1333 patients; 970 simulation, 363 control) met inclusion criteria. Breast surgery patients using simulation showed higher satisfaction with appearance (Breast-Q: 75.0 vs 58.1), surgical outcomes (84.9% vs 78.8%), and psychosocial well-being. Simulation patients reported higher satisfaction with the simulation experience (95.4%) and greater trust in their surgeon (95.2%), with lower complication rates (4.1% vs 41.5%). In facial surgery, simulation users demonstrated greater overall satisfaction (79.2% vs 67.3%) and improved understanding of outcomes. Perceived accuracy was higher in breast (91.0%) than facial surgery (74.1%). Across procedures, simulation enhanced shared decision-making and surgeon-patient rapport. Conclusion: Current evidence suggests that preoperative simulation may enhance patient satisfaction, trust, and engagement in plastic surgery, particularly in breast procedures. However, findings are based on heterogeneous studies with diverse patient populations, simulation technologies, and outcome measures. Further prospective comparative studies using standardized PRO measures are needed to better define the role of preoperative simulation across aesthetic and reconstructive plastic surgery.
- 31 August 2026
- Published by SAGE Publications in Plastic Surgery
Open AccessPatient Perspective on Preoperative Simulation in Plastic Surgery: A Systematic Review of Patient-Reported Outcomes
Introduction: Preoperative simulation technologies are increasingly utilized in plastic surgery to enhance surgical planning and patient communication. While their technical benefits have been established, the impact on patient-reported outcomes (PROs), in particular satisfaction and perceived accuracy, remain underexplored. This systematic review evaluated the effect of preoperative simulation on patient-reported satisfaction, decision-making, and perceived accuracy in breast and facial aesthetic plastic surgery. Methods: A systematic search of MEDLINE, Embase, and Cochrane databases up to April 2025 identified studies reporting PROs in adult patients undergoing breast (aesthetic or reconstructive) or facial aesthetic surgery with preoperative simulation. Data on demographics, simulation type, satisfaction, accuracy, and complications were extracted and analyzed. Results: Seventeen studies (1333 patients; 970 simulation, 363 control) met inclusion criteria. Breast surgery patients using simulation showed higher satisfaction with appearance (Breast-Q: 75.0 vs 58.1), surgical outcomes (84.9% vs 78.8%), and psychosocial well-being. Simulation patients reported higher satisfaction with the simulation experience (95.4%) and greater trust in their surgeon (95.2%), with lower complication rates (4.1% vs 41.5%). In facial surgery, simulation users demonstrated greater overall satisfaction (79.2% vs 67.3%) and improved understanding of outcomes. Perceived accuracy was higher in breast (91.0%) than facial surgery (74.1%). Across procedures, simulation enhanced shared decision-making and surgeon-patient rapport. Conclusion: Current evidence suggests that preoperative simulation may enhance patient satisfaction, trust, and engagement in plastic surgery, particularly in breast procedures. However, findings are based on heterogeneous studies with diverse patient populations, simulation technologies, and outcome measures. Further prospective comparative studies using standardized PRO measures are needed to better define the role of preoperative simulation across aesthetic and reconstructive plastic surgery.
- Open Access
- 8 December 2025
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 15 (12) , 611
Three-Dimensional Printing in Hand Surgery: What Is New? A Systematic Review
Aim: Preoperative planning and in-office patient education are essential elements of clinical management in patients afflicted with hand injuries. Three-dimensional (3D) printing aims to tackle these challenges by converting feedstock material into solid replicas. The purpose of this study was to review the clinical uses for 3D printing in hand surgery to identify approaches for delivering more personalized treatment strategies. Method: A systematic review was completed following PRISMA guidelines using Medline, Embase, and CINAHL databases, identifying studies published between 2013 and January 2025. A two-stage screening process, involving title, abstract, and full text reviews, was performed independently by two reviewers. Eligible studies included those involving patients with hand or wrist injuries (up to the distal radius) where 3D printing was utilized for diagnosis, surgical intervention, or rehabilitation. Results: The review included 751 patients (mean age: 38 years, range: 5–81 years) across 58 studies. The distal radius was the most commonly studied anatomical region (47%, N = 27), followed by the scaphoid (19%, N = 11). Key applications of 3D printing included preoperative planning (19%, N = 11), patient education (5%, N = 3), medical training (7%, N = 4), intra-operative assistance (38%, N = 22), splinting and casting (19%, N = 11), and prothesis and functional reconstruction (12%, N = 7). Conclusions: Despite its early stage of adoption in hand surgery, 3D printing has shown advantages, especially in enabling more personalized treatment strategies by improving intra-operative assistance, preoperative planning, and patient education. Further research is required to determine whether it positively affects postoperative outcomes, to calculate the cost–benefit ratio, and to compare its usage against standards of care.
- 8 December 2025
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 15 (12) , 611
Open AccessThree-Dimensional Printing in Hand Surgery: What Is New? A Systematic Review
Aim: Preoperative planning and in-office patient education are essential elements of clinical management in patients afflicted with hand injuries. Three-dimensional (3D) printing aims to tackle these challenges by converting feedstock material into solid replicas. The purpose of this study was to review the clinical uses for 3D printing in hand surgery to identify approaches for delivering more personalized treatment strategies. Method: A systematic review was completed following PRISMA guidelines using Medline, Embase, and CINAHL databases, identifying studies published between 2013 and January 2025. A two-stage screening process, involving title, abstract, and full text reviews, was performed independently by two reviewers. Eligible studies included those involving patients with hand or wrist injuries (up to the distal radius) where 3D printing was utilized for diagnosis, surgical intervention, or rehabilitation. Results: The review included 751 patients (mean age: 38 years, range: 5–81 years) across 58 studies. The distal radius was the most commonly studied anatomical region (47%, N = 27), followed by the scaphoid (19%, N = 11). Key applications of 3D printing included preoperative planning (19%, N = 11), patient education (5%, N = 3), medical training (7%, N = 4), intra-operative assistance (38%, N = 22), splinting and casting (19%, N = 11), and prothesis and functional reconstruction (12%, N = 7). Conclusions: Despite its early stage of adoption in hand surgery, 3D printing has shown advantages, especially in enabling more personalized treatment strategies by improving intra-operative assistance, preoperative planning, and patient education. Further research is required to determine whether it positively affects postoperative outcomes, to calculate the cost–benefit ratio, and to compare its usage against standards of care.
- Open Access
- 26 October 2025
- Published by Baishideng Publishing Group Inc. in World Journal of Clinical Cases
- Vol. 13 (30) , 109539
Complications of auricular cartilage harvest in rhinoplasty: Keloid and epidermal cyst formation
Keloid scars and epidermoid cysts present unique challenges in plastic surgery, often requiring distinct diagnostic and therapeutic approaches. Keloid scars result from dysregulated wound healing characterized by collagen overproduction and inflammatory states. In contrast, epidermoid cysts are cutaneous lesions lined with keratinized epithelium, with the rare complication of development into squamous cell carcinoma. A rare clinical dilemma is when epidermoid cysts arise within keloidal scar tissue. In this case, effective management involves meticulous diagnostic approaches, including ultrasonography and histopathological examination, to identify coexisting cysts within scar tissue. In the few studies reporting this rare occurrence, various treatment protocols exist consisting of various combinations of surgical excision, intralesional corticosteroid injections, chemotherapeutic agents, laser therapy, radiotherapy, isotretinoin, and tranilast. As advancements in the comprehension and treatment of epidermoid cysts within keloid scars progress, customized therapeutic approaches provide promise for enhancing patient outcomes and quality of life.
- 26 October 2025
- Published by Baishideng Publishing Group Inc. in World Journal of Clinical Cases
- Vol. 13 (30) , 109539
Open AccessComplications of auricular cartilage harvest in rhinoplasty: Keloid and epidermal cyst formation
Keloid scars and epidermoid cysts present unique challenges in plastic surgery, often requiring distinct diagnostic and therapeutic approaches. Keloid scars result from dysregulated wound healing characterized by collagen overproduction and inflammatory states. In contrast, epidermoid cysts are cutaneous lesions lined with keratinized epithelium, with the rare complication of development into squamous cell carcinoma. A rare clinical dilemma is when epidermoid cysts arise within keloidal scar tissue. In this case, effective management involves meticulous diagnostic approaches, including ultrasonography and histopathological examination, to identify coexisting cysts within scar tissue. In the few studies reporting this rare occurrence, various treatment protocols exist consisting of various combinations of surgical excision, intralesional corticosteroid injections, chemotherapeutic agents, laser therapy, radiotherapy, isotretinoin, and tranilast. As advancements in the comprehension and treatment of epidermoid cysts within keloid scars progress, customized therapeutic approaches provide promise for enhancing patient outcomes and quality of life.
- Open Access
- 18 July 2025
- Published by Oxford University Press (OUP) in Journal of Burn Care & Research
- Vol. 46 (6) , 1269-1275
The Utility of Fat Grafting to Manage Burn Scars: A Systematic Review
Secondary management of thermal injuries remains a challenging and relevant topic for plastic and nonplastic burn surgeons alike. Burn scars are associated with both functional limitations and aesthetic challenges for patients. While various treatment modalities exist for the management of these scars, no gold standard has been established. Fat grafting has been used in various reconstructive contexts, and studies have demonstrated improvement in skin texture and contour following infiltration. This systematic review aims to examine the available evidence on outcomes following fat grafting for the management of burn scars. A search of Medline, EMBASE, and Cochrane Library databases was conducted from their inception until November 2024. Published articles examining outcomes of fat grafting for thermal injury scars were identified, screened, and data were extracted following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. A total of 10 740 articles were screened, yielding 14 eligible studies for data extraction, accounting for 885 patients. All studies reported improvement of scars postoperatively. Nine out of 14 studies used a subjective clinical assessment, 1 study did not report pretreatment measurements, and the other 8 studies all found improved outcomes based on clinician assessment. One study reported Vancouver Scar Scale (VSS) scores and another reported modified VSS scores. Three studies utilized POSAS and the mean difference was an improvement of 7.28 (MCID <1). This review suggests that autologous fat grafting and adipose-derived stem cells show promising results for improving scar quality, function, and patient satisfaction following burn injury. Further studies, particularly prospective in nature, with standardized outcome measurements are needed to substantiate subjective clinical improvement. The authors recommend utilizing POSAS or VSS for future studies investigating burn scar treatments.
- 18 July 2025
- Published by Oxford University Press (OUP) in Journal of Burn Care & Research
- Vol. 46 (6) , 1269-1275
Open AccessThe Utility of Fat Grafting to Manage Burn Scars: A Systematic Review
Secondary management of thermal injuries remains a challenging and relevant topic for plastic and nonplastic burn surgeons alike. Burn scars are associated with both functional limitations and aesthetic challenges for patients. While various treatment modalities exist for the management of these scars, no gold standard has been established. Fat grafting has been used in various reconstructive contexts, and studies have demonstrated improvement in skin texture and contour following infiltration. This systematic review aims to examine the available evidence on outcomes following fat grafting for the management of burn scars. A search of Medline, EMBASE, and Cochrane Library databases was conducted from their inception until November 2024. Published articles examining outcomes of fat grafting for thermal injury scars were identified, screened, and data were extracted following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. A total of 10 740 articles were screened, yielding 14 eligible studies for data extraction, accounting for 885 patients. All studies reported improvement of scars postoperatively. Nine out of 14 studies used a subjective clinical assessment, 1 study did not report pretreatment measurements, and the other 8 studies all found improved outcomes based on clinician assessment. One study reported Vancouver Scar Scale (VSS) scores and another reported modified VSS scores. Three studies utilized POSAS and the mean difference was an improvement of 7.28 (MCID <1). This review suggests that autologous fat grafting and adipose-derived stem cells show promising results for improving scar quality, function, and patient satisfaction following burn injury. Further studies, particularly prospective in nature, with standardized outcome measurements are needed to substantiate subjective clinical improvement. The authors recommend utilizing POSAS or VSS for future studies investigating burn scar treatments.
- 8 February 2025
- Published by Elsevier in Journal of Hand and Microsurgery
- Vol. 17 (3) , 100223
Safety and efficacy of platelet-rich plasma injections in basal thumb osteoarthritis; should we offer it or not?
- 8 February 2025
- Published by Elsevier in Journal of Hand and Microsurgery
- Vol. 17 (3) , 100223
Safety and efficacy of platelet-rich plasma injections in basal thumb osteoarthritis; should we offer it or not?
- Open Access
- 1 December 2024
- Published by AME Publishing Company in Annals of Translational Medicine
- Vol. 12 (6) , 108
Redefining tomorrow: the evolution of plastic and reconstructive surgery
Redefining tomorrow: the evolution of plastic and reconstructive surgery
- 1 December 2024
- Published by AME Publishing Company in Annals of Translational Medicine
- Vol. 12 (6) , 108
Open AccessRedefining tomorrow: the evolution of plastic and reconstructive surgery
Redefining tomorrow: the evolution of plastic and reconstructive surgery
- Open Access
- 18 February 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (4) , 1148
Clinical, Radiologic, and Functional Outcomes following Bone Grafting for Metacarpal Non-Unions: A Systematic Review
Objectives: Metacarpal non-unions are complex hand defects that can lead to severe hand impairment. Treatment may require the use of artificial or autologous bone grafts. This systematic review aims to describe the outcomes of bone grafting following metacarpal non-union in an attempt to establish an optimal therapeutic protocol for this complication. Methods: A systematic review was conducted in adherence with PRISMA guidelines. Data collection and analysis were performed in duplicate and confirmed by a third investigator. Our primary outcomes focused on radiological time to bone fusion and rates of non-union. Additionally, functional outcomes and complications were analyzed as means of central tendency. Results: Eighteen studies were included in the systematic review, accounting for a total of 47 patients. The average follow-up time was 12.4 months. Fourteen studies analyzed radiological outcomes, with atrophic non-union representing the most common type. The time to bone fusion, assessed radiologically, following bone graft was an average of 6.9 months (n = 14), with a 100% rate of union in 42 patients. Regarding patient-reported pain improvement, 76% of patients experienced pain relief. Moreover, all patients reported a complete subjective return to baseline hand function. Adverse events, limited to hematoma and seroma, were seen in three patients, representing a complication rate of 11.8% in the examined population. Conclusions: Metacarpal non-union can be treated successfully via vascularized and non-vascularized bone grafting. Based on the available evidence, bone grafts demonstrate favorable union rates, post-operative pain reduction, hand function recovery, earlier bone fusion times, and minimal complications in the context of metacarpal non-union management.
- 18 February 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (4) , 1148
Open AccessClinical, Radiologic, and Functional Outcomes following Bone Grafting for Metacarpal Non-Unions: A Systematic Review
Objectives: Metacarpal non-unions are complex hand defects that can lead to severe hand impairment. Treatment may require the use of artificial or autologous bone grafts. This systematic review aims to describe the outcomes of bone grafting following metacarpal non-union in an attempt to establish an optimal therapeutic protocol for this complication. Methods: A systematic review was conducted in adherence with PRISMA guidelines. Data collection and analysis were performed in duplicate and confirmed by a third investigator. Our primary outcomes focused on radiological time to bone fusion and rates of non-union. Additionally, functional outcomes and complications were analyzed as means of central tendency. Results: Eighteen studies were included in the systematic review, accounting for a total of 47 patients. The average follow-up time was 12.4 months. Fourteen studies analyzed radiological outcomes, with atrophic non-union representing the most common type. The time to bone fusion, assessed radiologically, following bone graft was an average of 6.9 months (n = 14), with a 100% rate of union in 42 patients. Regarding patient-reported pain improvement, 76% of patients experienced pain relief. Moreover, all patients reported a complete subjective return to baseline hand function. Adverse events, limited to hematoma and seroma, were seen in three patients, representing a complication rate of 11.8% in the examined population. Conclusions: Metacarpal non-union can be treated successfully via vascularized and non-vascularized bone grafting. Based on the available evidence, bone grafts demonstrate favorable union rates, post-operative pain reduction, hand function recovery, earlier bone fusion times, and minimal complications in the context of metacarpal non-union management.